Synopsis of recent research by authors named "Alexey Belkin"
- Alexey Belkin's research focuses on the mechanisms by which various proteins, particularly transglutaminases and the VLDL receptor, influence cellular interactions, migration, and the development of diseases such as melanoma and vascular conditions.
- Recent findings highlight the dual role of the metastasis suppressor NME1 in controlling melanoma cell motility and promoting genomic stability through fibronectin expression, as well as the impact of transglutaminase 2 on vascular smooth muscle cell signaling and neointima formation.
- Belkin's studies also explore the therapeutic potential of disrupting key protein interactions, such as those between tissue transglutaminase and fibronectin, to inhibit cancer cell adhesion and metastasis, contributing to a broader understanding of disease mechanisms and potential treatments.
